According to a March 11 announcement, the Oregon Psilocybin Society, a campaign to legalize psilocybin mushrooms, has collected 112,020 valid signatures to qualify for the November ballot. The interest in using psychedelics for mental health continues to be a growing phenomenon in 2020, with efforts to decriminalize or legalize substances on the city and state levels.
The Oregon Psilocybin Society began collecting signatures last year. Under the campaign’s proposed act, called the Oregon Psilocybin Services Act, adults would be able to consume psychedelic mushrooms under the supervision of a doctor.
“We’re excited about the public support we’ve gotten so far and we’re looking forward to giving Oregon voters the opportunity to create the first statewide psilocybin therapy program in the country,” campaign manager Sam Chapman told Marijuana Moment.
Under the proposed act, there is no defined list of qualifying conditions, such as in numerous medical cannabis bills. Retail sales of psilocybin mushrooms, however, would not be tolerated.
A competing measure, which would only decriminalize psilocybin mushrooms and other drugs is called the Drug Treatment and Recovery Act. That bill also collected enough signatures to qualify for the November ballot.
The Oregon Psilocybin Society, which began signature gathering last year, is within striking distance of the required 112,020 valid signatures from registered voters needed to qualify for the November ballot.https://t.co/krrlLjeywx
— Shroom Street (@ShroomStreet) March 11, 2020
Efforts at the city level have already materialized. Denver, Colorado became the first city to decriminalize psilocybin mushrooms last May. Oakland, California followed, decriminalizing psilocybin mushrooms as well as other entheogenic plants and fungi. A separate bill would legalize psilocybin mushrooms in Oakland. A statewide effort to decriminalize psilocybin mushrooms is also underway in California.
Studies are rolling out with mounting evidence to suggest that psilocybin mushrooms may be effective for depression, or even a